Showing results (11-20 of 87) with videos related to
Sort By:
Pageof 9
Clinical Prostate Cancer|March 30, 2004
Antisense therapy: recent advances and relevance to prostate cancerLuba Benimetskaya, C A SteinClinical Prostate Cancer|March 26, 2004
Complications of androgen-deprivation therapy for prostate cancerJeffrey M Holzbeierlein, Erik P Castle, J Brantley ThrasherClinical Prostate Cancer|March 26, 2004
Weekly docetaxel in elderly patients with prostate cancer: efficacy and toxicity in patients at least 70 years of age compared with patients younger than 70 yearsTomasz M Beer, William Berry, Emily M Wersinger, et al.Clinical Prostate Cancer|March 26, 2004
Comparison of total prostate-specific antigen and derivative levels in a screening population of black, white, and Korean-American menJae Park, Lori J Sokoll, Debra J Bruzek, et al.Clinical Prostate Cancer|March 26, 2004
Characterization of prostate cancer missed by sextant biopsyJohn B Bak, Steve K Landas, Gabriel P HaasClinical Prostate Cancer|March 26, 2004
Algorithms for prostate-specific antigen recurrence after treatment of localized prostate cancerMichael W Kattan, James EasthamClinical Prostate Cancer|March 26, 2004
Prostate cancer on the internet: impact on patients and how technology helps physicians and researchersMichael Bergen, Karl Lewis, Robert Chen, et al.Clinical Prostate Cancer|March 26, 2004
Radiation therapy for increasing prostate-specific antigen levels after radical prostatectomyCarlos A Perez, Jeff M Michalski, Kathy Baglan, et al.Clinical Prostate Cancer|January 7, 2005
Protease-activated receptor 1: a role in prostate cancer metastasisTa-Chun Yuan, Ming-Fong LinClinical Prostate Cancer|March 30, 2004
Changes in body composition during hormonal therapy for prostate cancerMatthew R SmithPageof 9